IPO11 Antibody (N-term) Blocking Peptide

Catalog Number: ABT-BP8772A
Article Name: IPO11 Antibody (N-term) Blocking Peptide
Biozol Catalog Number: ABT-BP8772A
Supplier Catalog Number: BP8772a
Alternative Catalog Number: ABT-BP8772A-500UG
Manufacturer: Abcepta
Category: Proteine/Peptide
Alternative Names: Importin-11, Imp11, Ran-binding protein 11, RanBP11, IPO11, RANBP11
IPO11 functions in nuclear protein import as nuclear transport receptor. It serves as receptor for nuclear localization signals (NLS) in cargo substrates and is thought to mediate docking of the importin/substrate complex to the nuclear pore complex (NPC) through binding to nucleoporin and the complex is subsequently translocated through the pore by an energy requiring, Ran-dependent mechanism. At the nucleoplasmic side of the NPC, Ran binds to the importin, the importin/substrate complex dissociates and importin is re-exported from the nucleus to the cytoplasm where GTP hydrolysis releases Ran. The directionality of nuclear import is thought to be conferred by an asymmetric distribution of the GTP-and GDP-bound forms of Ran between the cytoplasm and nucleus (By similarity). It mediates the nuclear import of UBE2E3, and of RPL12 (By similarity).
NCBI: 51194
UniProt: Q9UI26
Form: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
Target: The synthetic peptide sequence used to generate the antibody AP8772a was selected from the N-term region of human IPO11. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.